Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.45 AUD | +16.88% | +25.00% | +30.43% |
Apr. 18 | Immutep Limited Appoints Leading Research Institute to Conduct First-In-Human Phase I Study of IMP761 | CI |
Apr. 18 | Immutep Taps Center for Human Drug Research for IMP761 Human Clinical Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.43% | 297M | |
+3.14% | 43.43B | |
+47.81% | 41.69B | |
+7.73% | 41.31B | |
-10.92% | 27.14B | |
+8.00% | 25.28B | |
-24.49% | 18.47B | |
+29.16% | 12.59B | |
+0.96% | 12.33B | |
+8.94% | 11.03B |
- Stock Market
- Equities
- IMM Stock
- News Immutep Limited
- Top Midday Gainers